Stephen J. Kanes
2018
Compensation breakdown
| Non-Equity Incentive Plan | $184,594 |
|---|---|
| Option Awards | $2,625,440 |
| Salary | $441,610 |
| Other | $2,419 |
| Total | $3,254,063 |
Kanes received $2.6M in option awards, accounting for 81% of the total pay in 2018.
Kanes also received $184.6K in non-equity incentive plan, $441.6K in salary and $2.4K in other compensation.
Rankings
In 2018, Stephen J. Kanes' compensation ranked 3,538th out of 14,244 executives tracked by ExecPay. In other words, Kanes earned more than 75.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,538 out of 14,244 | 75th |
Division Manufacturing | 1,307 out of 5,758 | 77th |
Major group Chemicals And Allied Products | 458 out of 2,119 | 78th |
Industry group Drugs | 377 out of 1,808 | 79th |
Industry Pharmaceutical Preparations | 290 out of 1,382 | 79th |
Pay ratio
| Stephen J. Kanes' Pay | $3,254,063 |
|---|---|
| Median Employee's Pay | $589,166 |
| Pay Ratio | to 1 |
In 2018, the annual total compensation of Stephen J. Kanes was $3,254,063.
The annual total compensation of the median employee at Sage Therapeutics was $589,166.
The ratio of Stephen J. Kanes' pay to the pay of median employee was therefore to one.
Kanes' colleagues
We found five more compensation records of executives who worked with Stephen J. Kanes at Sage Therapeutics in 2018.
2018
Jeffrey Jonas
Sage Therapeutics
Chief Executive Officer
2018
Michael Cloonan
Sage Therapeutics
Chief Business Officer
2018
Anne Cook
Sage Therapeutics
General Counsel
2018
Albert Robichaud
Sage Therapeutics
Chief Scientific Officer
2018
Kimi Iguchi
Sage Therapeutics